Hoban, Daryl J.;
Bouchillon, Samuel K.;
Hawser, Stephen P.;
Badal, Robert E.;
LaBombardi, Vincent J.;
DiPersio, Joseph
Susceptibility of Gram-Negative Pathogens Isolated from Patients with Complicated Intra-Abdominal Infections in the United States, 2007-2008: Results of the Study for Monitoring Antimicrobial Resistance Trends (SMART)
Sie können Bookmarks mittels Listen verwalten, loggen Sie sich dafür bitte in Ihr SLUB Benutzerkonto ein.
Medientyp:
E-Artikel
Titel:
Susceptibility of Gram-Negative Pathogens Isolated from Patients with Complicated Intra-Abdominal Infections in the United States, 2007-2008: Results of the Study for Monitoring Antimicrobial Resistance Trends (SMART)
Beteiligte:
Hoban, Daryl J.;
Bouchillon, Samuel K.;
Hawser, Stephen P.;
Badal, Robert E.;
LaBombardi, Vincent J.;
DiPersio, Joseph
Erschienen:
American Society for Microbiology, 2010
Erschienen in:Antimicrobial Agents and Chemotherapy
Beschreibung:
<jats:title>ABSTRACT</jats:title>
<jats:p>
During 2007-2008, 1,036 Gram-negative bacilli were isolated from patients with complicated intra-abdominal infections in the United States. Against members of the family
<jats:italic>Enterobacteriaceae</jats:italic>
, the most active agents
<jats:italic>in vitro</jats:italic>
were ertapenem, imipenem, and amikacin, while the least active agent was ampicillin-sulbactam. Ertapenem and imipenem were active against all extended-spectrum-beta-lactamase (ESBL)-positive
<jats:italic>Escherichia coli</jats:italic>
. Antimicrobial resistance in Gram-negative bacilli isolated from patients with complicated intra-abdominal infections in the United States continues to increase.
</jats:p>